
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol.
Sec. Cancer Imaging and Image-directed Interventions
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1555315
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: To investigate the value of intratumoral and peritumoral MRI radiomic models in predicting bone metastasis of prostate cancer patients using T2WI combined with ADC images.A total of 144 patients with prostate cancer who underwent preoperative MRI (T2WI and DWI) were retrospectively included. All patients were categorized into two groups based on the presence of bone metastasis. The radiomics features were calculatd for the entire tumor and 3mm-peritumoral components on pre-processed T2WI combined with ADC images. The radiomics models based on intratumoral features, peritumoral features as well as their merged features were respectively constructed. The independent risk factors of bone metastasis of prostate cancer were used to constructed clinical prediction model. The performance of the clincal model, radiomics models and clinic-imaging combined models was evaluated by the receiver operating characteristic curve and compared with the bootstrap methods. T-test was used to compare the evaluation indicators of different prediction models.The clinic-imaging combined model had the best predictive efficacy among all models. The area under the curve (AUC) of the clinic-imaging combined model for predicting bone metastasis of prostate cancer in the training dataset and test dataset were 0.937 and 0.893, respectively. The accuracy, sensitivity and specificity of this model in predicting bone metastasis of prostate cancer in the training dataset were 84.2%, 91.2% and 80.6%, respectively; the accuracy, sensitivity and specificity of the testing dataset were 76.7%, 73.3% and 78.6%, respectively.Conclusions: T2WI and ADC intratumoral and peritumoral radiomic models can be used to noninvasively predict the primary diagnosis of PCa BM, and peritumoral radiomic model can add independent predictive value. And the clinic-imaging combined model has the better predictive value.
Keywords: Magnetic Resonance Imaging, T2WI, ADC, prostate cancer, bone metastasis, Radiomics
Received: 04 Jan 2025; Accepted: 19 Feb 2025.
Copyright: © 2025 Lin, He and You. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ruixiong You, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.